The pathophysiology of the hemolytic uremic syndrome

Current Opinion in Nephrology and Hypertension

Volumn 8, Issue 4, 1999, Pages 459-464

  Andreoli, Sharon P ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN;

ACUTE KIDNEY FAILURE; ARTICLE; CELL DAMAGE; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; KIDNEY TUBULE EPITHELIUM; MESANGIUM CELL; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; SHIGA-LIKE TOXIN I;

EID: 0033405651     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199907000-00010     Document Type: Article

References (44)

1. Mead PS, Griffin PM. Escherichia coli 0157:H7. Lancet 1998; 352:1207-1212.
2. Repetto HA. Epidemic hemolytic uremic syndrome in children. Kidney Int 1997; 52:1708-1719. These two articles are very good reviews of the epidemiology or clinical characteristics of VTEC infections and HUS.
3. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli 0157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995; 33:364-368.
4. Su C, Brandt LJ. Escherichia coli 0157:H7 infection in humans. Ann Intern Med 1995; 123:698-714.
5. Rowe PC, Orrbine E, Wells GA, Yetisir E, Clulow M, McLaine PN. Risk of hemolytic uremic syndrome after sporadic Escherichia coli 0157:H7 infection: results of a Canadian collaborative study. J Pediatr 1998; 132:777-782.
6. Brandt JR, Fouser LS, Watkins SL, Zelikovic I, Tarr PI, Nazar-Stewart V, Avner ED. Escherichia coli 0157-H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr 1994; 125:519-526.
7. Moghal NE, Ferreira MAS, Howie AJ, Milford DV, Raafat F, Taylor CM. The late histologic finding in diarrhea associated hemolytic uremic syndrome. J Pediatr 1998, 133:220-223.
8. Caletti MG, Gallo G, Gianantonio CA. Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome. Pediatr Nephrol 1996; 10:687-692.
9. Inward CD, Howie AJ, Fitzpatrick MM, Rafaat F, Milford DV, Taylor CM. Renal histopathology in fatal cases of diarrhea associated hemolytic uremic syndrome. Pediatr Nephrol 1997, 11:556-559.
10. van Setten PA, van Hinsbergh VWM, van den Heuvel LPWJ, Preyers F, Dijkman HBPM, Assmann KJM et al. Monocytes chemoattractant protein-1 and interleukin-8 levels in urine and serum of patients with hemolytic uremic syndrome. Pediatr Res 1998; 43:759-767.
11. Yamasaki S, Takeda Y. Enterohemorrhagic Escherichia coli 0157:H7 episode in Japan with a perspective on vero toxins (shiga-like txins). J Toxicol-Toxin Rev 1997; 16:229-240.
12. Cody SH, Glynn K, Farrar JA, Cairns KL, Griffin PM, Kobayashi J et al. An outbreak of Escherichia coli 0157:H7 infection from unpasteurized commercial apple juice. Ann Intern Mad 1999; 130:202-209.
13. Parry SM, Salmon RL, Willshaw GA, Cheasty T. Risk factors for and prevention of sporadic infectious with verocytotoxin (shiga toxin) producing Escherichia coli 0157. Lancet 1998, 351:1019-1022.
14. Voss E, Paton AW, Manning PA, Paton JC. Molecular analysis of shiga toxigenic Escherichia coli 0111:H proteins which react with sera from patients with hemolytic uremic syndrome. Infect Immun 1998; 66:1467-1472.
15. Henning PH, Tham ECB, Martin AA, Beare TH, Jureidinid KF. Hemolyticuremic syndrome outbreak caused by Escherichia coli 0111:H: clinical outcomes. Mad J Aust 1998; 168:552-555.
16. Hashimoto H, Mizukoshi K, Nishi M, Kawakita T, Hasui S, Kato Y et al. Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributing to shiga toxin 1-producing Escherichia coli 0118:H2 at a junior high school in Japan. Pediatrics 1999; 103:e2.
17. Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI. Predictors of hemolytic uremic syndrome in children during a larger outbreak of Escherichia coli 0157:H7 infections. Pediatrics 1997; 100:e12.
18. Warwicker P, Goodship TJH, Donne RL, Pirson Y, Nicholls A, Ward RM et al. Genetic studies into inherited and sporadic hemolytic syndrome. Kidney Int 1998; 53:836-844.
19. Keusch GT, Acheson DWK. Thrombotic thrombocytopenia purpura associated with shiga toxins. Semin Hematol 1997; 34:106-116.
20. Paton JC, Paton AW. Pathogenesis and diagnosis of shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998; 11:450-479. These two articles are excellent reviews of the biology of verocytotoxins and the Gb3 verocytotoxin receptor.
21. Acheson DWK, Moore R, DeBreuler S. Translocation of Shiga-like toxins across polarized intestinal cells in tissue culture. Infect Immun 1996; 64:3294-3300.
22. Uchida H, Kiyokawa N, Horie H, Fujimoto J, Takeda T. The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr Res 1999; 45:133-137. This is the first study demonstrating verocytotoxin-1 and verocytotoxin-2 in the kidney of patients with HUS.
23. van Setten PA, van Hinsbergh VWM, van der Velden TJAN, van de Kar NCAJ, Vermeer M, Mahan JD et al. Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997; 51:1245-1256. Human glomerular endothelial cells are very difficult to culture and this paper characterizes the response of human glomerular endothelial cells to verocytotoxinmediated injury.
24. Kiarash A. Boyd B, Lingwood CA. Glycosphingolipid receptor function is modified by fatty acid content. J Biol Chem 1994; 269:1138-1146.
25. Sandvig K, Garred O, van Helvoort A, van Meer G, van Deurs B. Importance of glycolipid synthesis for butyric acid induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells. Mol Biol Cell 1996; 7:1391-1404.
26. Arab S, Lingwood CA. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriosyl ceramide fatty acid isoform traffic. J Cell Physiol 1998, 117:646-660. This article demonstrates that alterations in the lipid content of the Gb3 receptor impacts upon the intracellular sorting of the toxin and sensitivity of the cell to cytotoxic effects of the toxin.
27. Bitzan MM, Wang Y, Lin J, Marsden PA. Verotoxin and ricin have novel effects on preproendotherin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest 1998; 101:372-382. This study describes important biological responses of sublethally injured endothelial cells to verocytotoxin.
28. Andreoli SP, Green DF. Verotoxin promotes nitric oxide generation in glomerular endothelial cells (GEC) and accelerates PMN mediated GEC injury [abstract]. J Am Soc Nephrol 1997; 8(Abstract):582.
29. Simon M, Learly TG, Hernandez JD, Abboud HA. Shiga toxin 1 elicits diverse biological response in mesangial cells. Kidney Int 1998; 54:1117-1127.
30. Van Setten PA, Van Hinsbergh VWM, Van den Heuvel LPWJ, Van der Velden TJAN, Van de Kar NCAJ, Krebbbers RJM, et al. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol 1997; 8:1877-1888.
31. Hughes AK, Sticklett PK, Kohan DE. Cytotoxic effect of shiga toxin-1 on human proximal tubular epithelial cells. Kidney Int 1998; 54:426-437.
32. Hughes AK, Stricklett PK, Kohan DE. Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. Kidney Int 1998; 54:1093-1106. These two studies highlight the potential importance of mesangial cells and renal tubular epithelial cells as targets of verocytotoxin-mediated biological responses and cytotoxicity.
33. Taghchi T, Uchida H, Kiyokawa N, Mori T, Sato N, Horie H, et al. Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 1998; 53:1681-1688.
34. Karpman D, Hakansson A, Perez MT, Isaksson C, Carlemalm E, Caprioli A, Svanborg C. Apoptosis of renal cortical cells in the hemolytic uremic syndrome: in vivo and in vitro studies. Infect Immun 1998; 66:636-644.
35. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Interleukin-8 and polymorphonuclear leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 1992; 42:951-956.
36. Walters MDS, Matthei IU, Kay R, Dillon MJ, Barrett TM. The polymorphonuclear leucocyte count in childhood hemolytic uraemic syndrome. Pediatr Nephrol 1989; 3:130-134.
37. Morigi M, Micheletti G, Figliuzzi M, Imberti B, Karmali MA, Remuzzi A, et al. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 1995; 86:4553-4558.
38. Harel Y, Silva M, Giroir B, Weinberg A, Clearly TB, Beutler B. A reporter transgene indicates renal specific induction of tumor necrosis factor (TNF) by shiga-like toxin, J Clin Invest 1993; 92:2110-2116.
39. Yuhas H, Kaminsky E, Mor M, Ashkenazi S. Induction of nitric oxide production in mouse macrophages by shiga toxin. J Med Microbiol 1996; 45:97-102.
40. Inward CD, Varagunam M, Milford DV, Taylor CM. Cytokines in hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch Dis Child 1997; 77:145-147.
41. Sakiri R, Ramegowda B, Tesh TL. Shiga toxin type 1 activates tumor necrosis factor-a gene transcription and nuclear translocation of the transcriptional activators nuclear factor kB and activator protein-1. Blood 1996; 92:558-566.
42. Grif K, Kierich MP, Karch H, Allerberger F. Strain-specific differences in the amount of shiga toxin released from enterohemorrhagic Escherichia coli 0157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 1998; 17:761-766.
43. Heerze LD, Kelm MA, Talbot JA, Armstrong GD. Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic associated diarrhea and pseudomembranous colitis. J Infect Dis 1994; 169:1291-1296.
44. Armstrong GD, Fodor E, Vanmaele R. Investigation of shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J Infect Dis 1991; 164;1160-1167.